Is Recursion Pharmaceuticals Stock (RXRX) Halal? A Complete Analysis

The Short Answer

Recursion Pharmaceuticals stock (RXRX) is considered halal under standard Sharia screening. Drug discovery and pharmaceutical research are permissible activities with no haram revenue line, and Recursion funds its research primarily through equity and partnership payments rather than interest-bearing debt, so it passes the debt screen.

The caveats are typical clinical-stage risks: ongoing losses, volatile ratios, and interest income on its cash runway that should be checked and purified.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

• Business activity screen: Is the company's primary business halal?
• Debt ratio: Total debt / market cap must be under 33%
• Interest income: Interest income / total revenue must be under 5%
• Haram revenue: Revenue from haram sources must be under 5%
• Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Recursion's Business Activity

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. Its activity is:

• AI-driven drug discovery: Using automation and machine learning to find new medicines
• Pipeline development: Advancing its own drug candidates through trials
• Pharma partnerships: Collaborating with large drug companies for milestone payments

Drug discovery and pharmaceutical research are permissible activities with no inherent haram revenue line.

Why RXRX Is Halal

1. Permissible Core Business

Pharmaceutical research that develops medicines is a halal activity that benefits patients. There is no gambling, alcohol, conventional banking, or other prohibited line at the heart of the business.

2. Equity-Funded Balance Sheet

Recursion funds its research primarily through equity and partnership payments, carrying little interest-bearing debt and holding a sizable cash runway, so the debt-to-market-cap ratio passes the 33% Sharia threshold.

3. Clinical-Stage Caveats

Recursion is pre-profit and speculative; its ratios should be re-screened against the latest filings, and interest income on its cash runway should be checked against the 5% threshold and purified.

Financial Ratios (2025)

Based on Recursion's most recent financial statements:

• Total Debt / Market Cap: Under the 33% threshold — equity-funded ✅
• Interest Income / Revenue: Verify against the 5% threshold and purify ⚠️
• Haram Revenue: Negligible (drug research) ✅
• Business Activity: Permissible — pharmaceutical research ✅

Verdict from Major Screening Agencies

Recursion Pharmaceuticals stock is generally screened as halal, with clinical-stage caution by:

• Zoya App — Typically compliant on the financial screens ✅
• Musaffa — Generally compliant, with purification of minor income ✅
• Most major Sharia advisory boards — Permissible activity, passes debt screen ✅

Bottom Line

Recursion Pharmaceuticals (RXRX) is halal for Muslim investors. The AI-driven drug discovery business is permissible, and the equity-funded balance sheet passes the debt screen. Investors should treat it as a speculative, clinical-stage holding, re-screen the financials regularly, and purify the minor portion of returns attributable to interest income on cash.

For Muslim investors seeking healthcare and AI exposure, compare RXRX with peers like Tempus AI (TEM) and Pfizer (PFE).